Managing Director, Versant Ventures
Dr. Thomas Woiwode, PhD
Dr. Thomas Woiwode has served on our Board of Directors since April 2014. Tom joined Versant Venture Management LLC in 2002 and has served as a Venture Partner since 2011 and as a Managing Director from July 2014 to July 2017. Tom also has served on the Board of Directors of Audentes Therapeutics since July 2013. During his time at Versant, Tom has served in a number of operating roles, most recently as Chief Operating Officer of Okairos, a biopharmaceutical company acquired by GlaxoSmithKline in May 2013. Tom also co-founded Euroventures, a wholly-owned biotechnology incubator within Versant, and in this role served as the founding Chief Business Officer of three biotech companies created within Versant. Tom received a Ph.D. in Organic Chemistry at Stanford University and a B.A. in English and a B.S. in Chemistry from the University of California, Berkeley.